Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
7,361 total articles
Microsoft’s recent pullback has compressed sentiment, creating a tactical long opportunity. The trade here is to initiate a position near $440 with a $520 target and a $400 stop, banking on renewed AI-driven cloud revenue and margin stabilization over the next six months. This is a measured, size-weighted entry for investors willing to ride through…
AMC Networks (AMCX) just closed multiple debt maneuvers that unlock up to $50M in buybacks and move heavy near-term maturities out to 2032. With free cash flow of $272M, an EV/EBITDA of ~4.2 and a market cap near $306M, the stock screens cheap. I’m upgrading to bullish and laying out a long-term (180 trading days) trade plan: entry $7.18, stop $5.3…
MarketAxess (MKTX) is a high-quality fintech franchise trading at about $6.1B market cap. The trade idea is a conditional long: enter around current levels while sizing for a mid-term turnaround in margins and volumes. Catalyst set includes trading volume rebounds, product adoption (Axess IQ), and continued buybacks/dividends. Risks include protoco…
VALE is trading at $16.20 with a market cap of roughly $73.5B and a 7.9% cash yield. Market commentary suggests an implied EV/EBITDA of ~4.8x for Vale - a level that looks attractive for a diversified iron-ore and nickel producer if commodity prices stabilize. This is a tactical mid-term long: entry $16.20, stop $14.75, target $18.50 over ~45 tradi…
Google's TurboQuant created headline volatility for memory names, but Micron's fundamentals - revenue momentum, strong cash generation, low leverage, and HBM scarcity - argue the sell-off is overdone. This trade targets $540 with disciplined risk controls and a 46-180 trading day horizon.
Johnson & Johnson's diversified medtech and pharmaceutical engine gives investors a low-volatility way to play a potential $25 billion multiple myeloma upside by 2030. At $243, the stock trades at ~22x earnings with a $585B market cap, 63 years of dividend raises and ~$19.3B in free cash flow — metrics that support a long-term buy. Trade plan provi…
Hut 8 is transitioning from crypto-mining legacy assets to large-scale AI and HPC infrastructure. The company's announced multi-gigawatt expansion program - anchored by strategic partners and backed by a clean balance sheet and a sizable digital-asset treasury - makes the current pullback an entry opportunity. This trade idea lays out precise entry…
Target Hospitality (TH) has re-rated off a steady stream of contract awards and improving top-line visibility. With market cap near $1.39B, positive free cash flow of $73.3M and minimal debt, the stock looks set to extend a breakout. This trade idea offers a clear entry, stop and target for a mid-term swing (45 trading days) while flagging valuatio…
Zoetis (ZTS) is trading near its 52-week low while retaining healthy margins, strong free cash flow and a mid-teens valuation relative to earnings and cash generation. This trade idea argues for a tactical long: entry at $117.90, stop at $108.00, and a target of $140.00 over a 45-trading-day horizon, with a case for longer-term upside if key segmen…
Delta's unique refinery exposure, healthy free cash flow, and conservative leverage make it a candidate to outperform peers if fuel volatility cools and travel demand stays resilient. With a market cap near $43.6B and EV/EBITDA of 3.8, the stock looks priced for disappointment. This trade targets a rebound toward $78 with a $60 stop, horizon 180 tr…
NiSource is a regulated utility with a tangible pathway to incremental demand from data center buildouts in the Midwest and a steady rate-base growth story. The valuation is not cheap, but regulatory support, recent execution, and technical momentum make a mid-to-long-term long trade attractive. Entry $47.00, target $53.00, stop $44.00. Long term (…
Nano Dimension's acquisitions (Desktop Metal closed; Markforged added) take the company from a niche electronic additive player toward a diversified, scale-enabled industrial 3D printing platform. With an implied combined revenue run-rate north of $200M, a reported pro-forma cash position cited in earlier filings, and a market cap of ~$344M, the ri…
UiPath (PATH) trades at roughly a $5.9B market cap with an enterprise value near $5.0B, about $960M in reported cash and $352M in annual free cash flow. Management is pivoting into agentic AI orchestration and recent product partnerships add credibility. With valuation stretched toward the cheap side of AI peers (P/S ~3.66, P/E ~20.9) and a tidy ba…
Mobileye still has technology and cash, but its growth narrative is under strain. The stock trades near $7.45 with a market cap of roughly $6.3B, heavy insider-driven M&A and conservative 2026 guidance have left the name rangebound. This trade idea favors a tactical short over a mid-term horizon while the company digests Mentee Robotics and OEM ord…
Check Point (CHKP) pulled back from 52-week highs amid geopolitical headlines and short-term noise. The company's Q4/2025 revenue of $745 million and full-year revenue of $2.725 billion, 42% operating margins, and $1.14 billion in free cash flow support a constructive trade. We lay out an actionable mid-term long trade with entry, stop, and target,…
Caterpillar is more than construction equipment. Recent commercial tie-ups around behind-the-meter generation and a reopening of infrastructure demand make CAT a compelling mid-term long. Valuation is rich by historical cyclicals standards, but orders-for-power and services durability support upside. Trade plan included: entry $710.00, stop $675.00…
TRX Gold (TRX) is a mid-tier Tanzania-focused producer showing rapid revenue and EBITDA growth, funded by operations and brownfield expansion rather than equity dilution. With fiscal 2025 revenue of $57.6M and EBITDA of $22M, a planned throughput increase and gold at multi-year highs, TRX offers an asymmetric risk-reward for a long trade. Entry $1.…
Eagle Point Credit (ECC) is a closed-end fund focused on CLO equity and junior debt tranches. The shares trade at a steep discount, with a current market cap of $522.0M and a quoted dividend yield above 40%. While NAV pressure from CLO markdowns has pushed the market price lower, recent insider buying reports and healthy distribution mechanics crea…
Blue Owl (OWL) has been hammered by private credit redemption headlines; the pullback to $8.57 leaves free cash flow and dividend yield metrics that look attractive versus the panic. This trade idea views the current weakness as a tactical buying opportunity with a high-risk stop and a long-term target reflecting recovery in private credit valuatio…
CMB.TECH completed the Golden Ocean merger and now controls ~250 vessels with a fleet value of $11.1B. The market caps the combined business at roughly $4.09B today, implying mid-cycle earnings expectations. With fleet renewal, newbuild deliveries and integration levers coming through 2026, I see room for earnings upside and a re-rating from here. …
Micron is trading at a market cap near $413B but still looks like an early-stage winner in the AI memory arms race. Strong FCF, healthy balance-sheet metrics and a dominant position in high-bandwidth memory create a pathway for Micron to capture outsized gains if AI compute growth continues. This trade lays out a clear entry, stop, targets, catalys…
DoubleVerify (DV) is a software-first ad measurement company with solid cash generation, low leverage, and a market cap of roughly $1.61B. Recent product launches and steady adoption in streaming create a re-rating path while the stock trades at modest multiples (EV/EBITDA ~10, P/FCF ~9.3). This trade idea proposes a long entry at $9.90, a $14.00 t…
KKR is trading near $91 with a market cap around $81.3B while continuing to generate meaningful realizations and strategic investments. Credit-markets headlines have pressured the sector, but KKR's diversified asset base, recent high-profile exits and active deal pipeline argue for a tactical long. This trade targets a rebound into the mid-teens ab…
ANI Pharmaceuticals (ANIP) has converted a string of revenue beats and rare-disease wins into material top-line growth. With 2025 revenue near $883M, management guiding for north of $1B in 2026, and free cash flow of $171M, ANIP looks reasonably priced at a $1.66B market cap. This trade proposes a long-term position with explicit entry, stop and ta…
Freehold Royalties offers direct oil exposure through a royalty model that minimizes operating capex and opex risk. With oil geopolitics keeping upside possible and royalty names showing relative resilience, a tactical long entry can capture a mid-term oil rebound while defining downside with a tight stop.
